Earnings call transcript: Manorama Industries posts strong Q1 2026 growth

Manorama Industries posted Q1 FY27 results with revenue up 39.5% YoY to INR 404 crore and PAT up 67.6% YoY to INR 79 crore, alongside EBITDA up 42.2% YoY to INR 106 crore and margin expansion (EBITDA margin to 26.3%, +49 bps; PAT margin to 19.5%, +326 bps). The stock jumped 8.44% to $1,751.45 after the quarter marked the first quarterly revenue above INR 400 crore, supported by higher volumes (~85% of revenue growth) and a stronger mix. Management guided fractionation capacity utilization for FY27 at 80–85% (internal target 85–90%) and expects INR 225–250 crore of CapEx in FY27 plus INR 500 crore QIP completion to fund expansion, including 4,500 tons of debottlenecking (capacity to ~52,000 tons by Q3 FY27).

Analysis

This is a quality print, but the investable takeaway is less about the headline growth and more about the widening moat around sourcing and conversion. The real winner is the company’s ability to turn West Africa access into a lower-cost, higher-control supply chain; that raises the bar for smaller specialty-fat processors that rely on spot sourcing and weaker logistics optionality. Downstream customers in confectionery/cosmetics also benefit from a more stable pricing model, which can support share gains versus less reliable competitors.

The near-term risk is that the market may be capitalizing a run-rate that still has non-repeatable support from FX and unusually clean employee costs. Freight inflation and shipment disruption matter because this business is effectively a spread business: if inbound logistics worsen faster than mix improves, EBITDA can lag revenue even with good volumes. The next 1-3 month catalyst is the debottlenecking completion; the 6-18 month story depends on whether the Africa build-out translates into lower raw-material volatility and not just higher working capital.

Contrarian view: consensus is likely underestimating how much of FY27-FY28 is execution, not demand. The stock has already moved toward its highs, so chasing the print is lower quality than waiting for either a pullback or hard evidence that utilization stays near 80% and the cash conversion cycle does not deteriorate. What would falsify the bullish case is any slippage in commissioning, gross margin drifting below the historical range for more than one quarter, or another equity-funded expansion need.

Key Decisions for Investors

• Buy MNOR on pullbacks toward INR 1,650-1,700, with a tactical stop on a close below INR 1,600; target INR 1,950-2,050 over 3-6 months if Q3 debottlenecking lands on time and utilization stays near 80%-85%.
• If listed options are available, use a Dec-2026 1,800/2,100 call spread in MNOR instead of outright stock to express the structural rerating thesis while capping downside from freight or execution slippage.
• Set a watch item, not a buy signal, on Q2/FY27 working-capital burn: if receivables/inventory absorb more than the QIP-funded balance sheet cushion, reduce exposure before the FY28 capex ramp.
• Take profits on a close above the 52-week high unless there is explicit evidence of margin durability; the current move may already discount the easy part of the story.